major side effects of semaglutide - an overview Ozempic: Semaglutide is a GLP-1

Because so many patients taking Ozempic experienced weight loss, Novo Nordisk, the company that owns semaglutide, went through the FDA testing process again

The small discrete size of the Afrezza inhaler device, as well as its rapid onset of action, makes it an attractive option for patients with T2D

Semaglutide and diet Healthy eating and exercise are recommended when taking semaglutide, regardless of whether youre taking the oral or injectable version

While these symptoms often reflect the medication's mechanism of action combined with altered biliary physiology, persistent or severe abdominal pain, vomiting, or signs of jaundice may indicate complications requiring urgent medical attention and discontinuation of semaglutide

Medical Testing and Ozempic: What to Tell Your Doctor Transparency with your healthcare provider about all medications you are taking is essential for safe and effective care